King Pharmaceuticals KG Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$7.43M-1,786% | —— | -$5.05M-1,078% | $69.93M+12,884% | -$394K— | ||
| $9K-50.0% | $299K+283% | -$2.82M-16,659% | $2.78M— | $18K— | ||
| $1.45M+9,560% | —— | —— | —— | $15K— | ||
| -$15.13M-1,628% | -$65.71M-30,460% | -$9.7M-1,895% | -$19.86M— | -$876K— | ||
| $53M— | $42.53M— | $16.08M— | $88.33M— | $0— | ||
| $486K— | —— | —— | —— | $0— | ||
| -$486K— | —— | —— | -$40M— | $0— | ||
| $36.83M+4,304% | —— | $6.22M+1,379% | $29.13M— | -$876K— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does King Pharmaceuticals generate?
- King Pharmaceuticals (KG) generated -$110.4M in operating cash flow over the trailing twelve months.
- Where does King Pharmaceuticals's cash flow data come from?
- Every line is extracted from King Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
